Preserved in Portico This version is not peer-reviewed
Need for Specialized Therapeutic Stem Cells Banks Equipped with Tumor Regression Enzymes and Anti-Tumor Genes
: Received: 25 April 2020 / Approved: 27 April 2020 / Online: 27 April 2020 (04:49:54 CEST)
A peer-reviewed article of this Preprint also exists.
Journal reference: J BiomedAllied Res. 2020
Stem cells are currently being used in many clinical trials for regenerative purposes. These are promising results for stem cells in the treatment of several diseases, including cancer. Nevertheless, there are still many variables which should be addressed before the application of stem cells for cancer treatment. One approach should be to establish well-characterized therapeutic stem cell banks to minimize the variation in results from different clinical trials and facilitate their effective use in basic and translational research.
Stem cells banks; Cancer; Cytosine deaminase; Tumor; Gene therapy
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.